Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114946
Status:
TERMINATED
Last Update Posted:
2006-05-29
First Post:
2005-06-20
Brief Title:
A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
A Randomized Open-Label Trial Comparing Two Avastin Bevacizumab-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer
Status:
TERMINATED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized open-label active-control multicenter trial comparing two oxaliplatinAvastin-based treatment sequences as first-line therapy for metastatic colorectal cancer The study is designed to compare the efficacy of these two treatment sequences with respect to progression free survival PFS and overall survival
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None